Electra Therapeutics, Inc. (ETRA) — research page
US · us-cm-kg/NASDAQ/ETRA · as of 2026-11-08
Identity and listing
Electra Therapeutics, Inc. is listed on NASDAQ under the ticker ETRA, with ISIN US2848251060. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is non-operating entity type (other), the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Electra Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | ETRA | source · 2026-11-08 |
| ISIN | US2848251060 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 35 filings in the window 2025-11-08 to 2026-11-08, across 12 filing days. The median gap between filing days is 3 days. The latest filing is dated 2026-11-05, 3 days before the record date of 2026-11-08, and is of type directors_dealings. The filings comprise 20 directors_dealings, 10 regulatory_filing, 4 prospectus and 1 corporate_news. On NASDAQ the median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4359 issuers. In the sector the median is 65.5 filings, a median cadence gap of 5.5 days and a median latency of 4.0 days across 176 issuers. The issuer's 35 filings are below the exchange median of 52 and below the sector median of 65.5.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 35 | 3 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | directors_dealings | 4 | 4 |
| 2026-11-05 | directors_dealings | 4 | 4 |
| 2026-10-29 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-09-28 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-09-28 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds two listing lines, both dated 2026-09-18. It holds no delisting, no name change, and no segment move; the segment move is not on the record because the exchanges' tier transfers are not EDGAR filings. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The issuer is listed and not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page, and the count is 0.
Open research
No openly published research notes were found on the record, and the count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's years sealed are 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the vintage is sealed. The live record began on 2026-09-12.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0002088082.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/ETRA (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://mcp.us-cm-kg.ai/record/NASDAQ/ETRA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US2848251060"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:bf2a818aeae486cd.